Drug
Interferon Beta-1a Inhalation Solution SNG001 clinical trials
How studies write it
Studies that test it under each name
Written with another drug
- SNG001
- 4
Studies by the year they started
4 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
Synairgen Research Ltd. (3) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Often tested with
Tested in the same studies.
Interferon beta-1a (4) · Bamlanivimab (1) · Amubarvimab (1) · Romlusevimab (1) · Cilgavimab and tixagevimab drug combination (1) · Camostat (1) · Ogalvibart (1) · Crexavibart (1)
Studies
Open first, then newest update. How each study uses Interferon Beta-1a Inhalation Solution SNG001 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral InfectionTerminatedPhase 2Synairgen Research Ltd.NCT06999603Written as SNG001
- ACTIV-2: A Study for Outpatients With COVID-19CompletedPhase 2/3National Institute of Allergy and Infectious Diseases (NIAID)NCT04518410Written as SNG001
- Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19CompletedPhase 3Synairgen Research Ltd.NCT04732949Written as SNG001
- Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) InfectionCompletedPhase 2Synairgen Research Ltd.NCT04385095Written as SNG001